Sex-hormone binding globulin as an indicator of the hepatic impacts of continuous combined hormone replacement regimens

Maturitas

Volumn 29, Issue 1, 1998, Pages 87-92

  Raudaskoski, Tytti ^a   Laatikainen, Timo ^b   Kauppila, Antti ^a  

^a OULU UNIVERSITY HOSPITAL   (Finland)

^b Helsinki City Maternity Hospital   (Finland)

Author keywords

Binding globulin; Gynecology; Hormone replacement; Sex hormone

Indexed keywords

ESTRADIOL; ESTRADIOL PLUS NORETHISTERONE ACETATE; ESTROGEN; LEVONORGESTREL; NORETHISTERONE ACETATE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; DRUG EFFECT; FEMALE; HORMONE SUBSTITUTION; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; INTRAUTERINE DRUG ADMINISTRATION; LIVER; ORAL DRUG ADMINISTRATION; POSTMENOPAUSE; PROTEIN BLOOD LEVEL; TRANSDERMAL DRUG ADMINISTRATION;

ADMINISTRATION, CUTANEOUS; ADMINISTRATION, ORAL; ADULT; BIOLOGICAL MARKERS; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; LEVONORGESTREL; MIDDLE AGED; POSTMENOPAUSE; SEX HORMONE-BINDING GLOBULIN; TESTOSTERONE;

EID: 0032550787     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5122(98)00003-6     Document Type: Article

References (23)

1. Campbell S, Whitehead MI Oestrogen therapy and the menopausal syndrome. Clin Obstet Gynecol. 4:1977;31-47.
2. Staland B Continuous treatment with natural oestrogens and progestogens. A method to avoid endometrial stimulation. Maturitas. 3:1981;145-156.
3. Dören M, Reuther G, Minne H, Schneider P Superior compliance and efficacy of continuous combined oral estrogen-progestogen replacement therapy in postmenopausal women. Am J Obstet Gynecol. 173:1995;1446-1451.
4. Raudaskoski T, Lahti E, Kauppila A, Apaja-Sarkkinen M, Laatikainen T Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints: clinical and endometrial responses. Am J Obset Gynecol. 172:1995a;114-119.
5. Carter GD, Holland SM, Alaghband-Zadeh J, Rayman G, Dorrington-Ward P, Wise PH Investigation of hirsutism: testosterone is not enough. Ann Clin Biochem. 20:1983;262-263.
6. Herbert V, Lan KS, Gottlieb CW, Bleicher SJ Coated charcoal immunoassay of insulin. J Clin Endocrinol. 25:1965;1375-1384.
7. Khan MS, Knowles BB, Aden DP, Rosner W Secretion of testosterone-estradiol-binding globulin by a human hepatoma-derived cell line. J Clin Endocrinol Metab. 53:1981;448-449.
8. Rosner W The functions of corticosteroid-binding globulin and sex hormone-binding globulin: recent advances. Endocr Rev. 11:1990;80-91.
9. Mashchak CA, Lobo RA, Dozono-Takano R, Eggena P, Nakamura RM, Brenner PF et al. Comparison of pharmacodynamic properties of various oestrogen formulations. Am J Obstet Gynecol. 144:1982;511-518.
10. Chetkowski RJ, Meldrum DR, Steingold KA, Randle D, Lu JK, Eggena P et al. Biologic effects of transdermal estradiol. New Engl J Med. 314:1986;1615-1620.
11. Rannevik G, Jeppsson S, Johnell O, Bjerre B, Laurell-Borulf Y, Svanberg L A longitudinal study of the perimenopausal transition: altered profiles of steroid and pituitary hormones, SHBG and bone mineral density. Maturitas. 21:1995;103-112.
12. Nestler JE, Strauss JF Insulin as an effector of human ovarian and adrenal steroid metabolism. Endocrinol Metab Clin. 4:1991;807-823.
13. Pedersen OD, Jensen HK Long-term treatment with transcutaneous estradiol and medroxyprogesterone acetate. Acta Obstet Gynecol Scand. 71:1992;593-598.
14. Wide L, Naessen T, Phillips DJ Effect of chronic daily oral administration of 17 beta-oestradiol and norethisterone on the isoforms of serum gonadotrophions in post-menopausal women. Clin Endocrinol Oxf. 42:1995;59-64.
15. Fink B, Svenstrup B, Bennett P, Micic S, Moller S Effect of oestrogen and progestagen on gonadotrophins and sex hormones in oophorectomized women. Eur J Obstet Gynecol Reprod Biol. 27:1988;145-152.
16. Victor A, Johansson EDB Effects of d-norgestrel induced decreases in sex hormone binding globulin capacity on the d-norgestrel levels in plasma. Contraception. 16:1977;115-123.
17. Suhonen SP, Allonen HO, Lähteenmäki P Sustained-release subdermal estradiol implants: a new alternative in estrogen replacement therapy. Am J Obstet Gynecol. 169:1993;1248-1254.
18. Farish E, Hart DM, Gray CE, Beastall G, Fletcher CD, Lindsay R Effects of treatment with oestradiol/levonorgestrel on bone, lipoproteins and hormone status in postmenopausal women. Clin Endocrinol. 31:1989;607-615.
19. El Makhzangy MN, Wynn V, Lawrence DM Sex hormone binding globulin capacity as an index of oestrogenicity or androgenicity in women on oral contraceptive steroids. Clin Endocrinol. 10:1979;39-45.
20. Blight LF, Judd SJ, White GH Relative diagnostic value of serum non-SHBG-bound testosterone, free androgen index and free testosterone in assessment of mild to moderate hirsutism. Ann Clin Biochem. 26:1989;311-316.
21. Kuusi T, Nikkilä EA, Tikkanen MJ, Sipinen S Effects of two progestins on hepatic endothelial lipase and high density lipoprotein2. Atherosclerosis. 54:1985;251-262.
22. Koh KK, Mincemoyer R, Bui MN, Csako G, Pucino F, Guetta V, Waclawiw M, Cannon RO Effects of hormone-replacement therapy on fibrinolysis in postmenopausal women. New Engl J Med. 336:1997;683-690.
23. Raudaskoski T, Tomas E, Paakkari I, Kauppila A, Laatikainen T Serum lipids and lipoproteins in postmenopausal women receiving transdermal oestrogen in combination with a levonorgestrel-releasing intrauterine device. Maturitas. 22:1995b;47-53.